07:31 AM EST, 11/12/2024 (MT Newswires) -- Oncolytics Biotech ( ONCY ) on Tuesday reported a narrower loss for the third quarter.

The net loss narrowed slightly to $9.5 million or $0.12 per share, from $9.9 million, or $0.14 per share, last year.

The company, which booked no revenue for the quarter, reported a cash position of $19.6 million as of Sept. 30, providing it with a projected cash runaway into 2025.

Oncolytics was last seen down US$0.03, to US$1.05 in U.S. premarket trade.